About the Company
We do not have any company description for PolyPid Ltd. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on PolyPid Ltd.
PolyPid Ltd. (NASDAQ:PYPD) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript August 13, 2025 PolyPid Ltd. misses on earnings expectations. Reported EPS is $-0.78 EPS, ...
PolyPid Ltd (PYPD) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Rising Expenses
PolyPid Ltd (PYPD) reports significant progress in clinical trials and regulatory plans, despite increased R&D and ...
PolyPid Reports Strong Phase 3 Results and Financial Update
PolyPid Ltd. ( ($PYPD) ) has released its Q2 earnings. Here is a breakdown of the information PolyPid Ltd. presented to its investors. PolyPid ...
PolyPid Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer
Dr. Tweezer-Zaks Transitions from the Company’s Board of Directors to Lead Medical Strategy Following Positive Phase 3 ...
PolyPid Ltd.
View PolyPid Ltd. PYPD stock quote prices, financial information, real-time forecasts, and company news from CNN.
PolyPid to Report First Quarter 2024 Financial Results and Operational ...
PolyPid is not responsible for the contents of third-party websites. Contacts: PolyPid Ltd. Ori Warshavsky COO – US 908-858-5995 IR@Polypid.com Investors: Brian Ritchie LifeSci Advisors 212-915-2578 ...
PolyPid Appoints New Chief Medical Officer Amid Strategic Advancements
PolyPid ( (PYPD)) has shared an announcement. PolyPid Ltd. announced the appointment of Dr. Nurit Tweezer-Zaks as Chief Medical Officer, effective August 18, 2025. Dr. Tweezer-Zaks, who has been on ...
PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results ...
PolyPid is not responsible for the contents of third-party websites. Contacts: PolyPid Ltd. Ori Warshavsky COO – US 908-858-5995 IR@Polypid.com Investors: Brian Ritchie LifeSci Advisors 212-915-2578 ...
PolyPid Ltd. (NASDAQ:PYPD) Q4 2023 Earnings Call Transcript
PolyPid Ltd. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greeting morning and welcome to the PolyPid Fourth ...
How Much Of PolyPid Ltd. (NASDAQ:PYPD) Do Insiders Own?
NasdaqGM:PYPD Earnings and Revenue Growth August 2nd 2021 PolyPid is not owned by hedge funds. Our data shows that Aurum Ventures MKI Ltd. is the largest shareholder with 9.3% of shares outstanding.
PolyPid Ltd. Announces Closing of Initial Public Offering and Full ...
PETAH TIKVA, Israel, June 30, 2020/ PRNewswire/-- PolyPid Ltd., a Phase 3 clinical-stage pharmaceutical company focused on developing targeted, locally administered and prolonged-release ...
Similar Companies
Loading the latest forecasts...